by EmpathiCSubstanceS | Jan 14, 2022 | Neuropathy, NN-Dimethyltryptamine, OCD, San Pedro Mescaline
The first results from Phase 3 trials testing MDMA-assisted psychotherapy for post-traumatic stress disorder (PTSD) have been announced. The extremely promising data are the first Phase 3 results to be revealed for any psychedelic-based therapy, paving the way for a...
by EmpathiCSubstanceS | Jan 14, 2022 | LSD, MDMA Sassafras Molly, Microdosing, Neuropathy, NN-Dimethyltryptamine, OCD, Pain, Parkinson's Disease
Another myth being commercialized is that psychedelic drugs will make you a peaceful, righteous human. The notion that the world’s problems would be solved if more people took entheogens is a hallucination in and of itself. However, there are countless examples of...
by EmpathiCSubstanceS | Jan 14, 2022 | Addiction, Alcoholism, Anxiety, Ayahuasca, Bipolar Disorder, Cancer, Cannabis Marijuana, CBC, Chronic Pain
Before you start a psychedelic venture or adventure, keep in mind that there are many psychedelic gimmicks that have long preceded the current “shroom boom.” As Alan Watts is purported to have said, “Anybody who tells you that he has some way of leading you to...
by EmpathiCSubstanceS | Jan 14, 2022 | Cluster Headaches, Depression, DMT, Kambo, LSD
The main focus on naturally occurring psychedelics has been on a few dozen species identified in North and South America. For example, the Western world knows of roughly 100 species of psychedelic mushrooms. Is this a bias from our bioprospecting or a true...
by EmpathiCSubstanceS | Jan 14, 2022 | Cancer, Cannabis Marijuana, Chronic Pain, Depression, LSD, Neuropathy, Pain, Psychotropics
A first-of-its-kind clinical trial has pitted a common antidepressant against psilocybin, the main psychedelic compound found in magic mushrooms. The results, recently published in the New England Journal of Medicine, are decidedly mixed with the primary depression...
